Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Auriga Partners

Investor type Micro VC
Founders Bernard Daugeras Jacques Chatain Patrick Bamas

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 169
Average round size
info
The average size of a deal this fund participated in
$11M
Portfolio companies 72
Rounds per year 7.04
Lead investments 17
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.57
Exits 35
Key employees 8
Stages of investment
Early Stage Venture
Late Stage Venture
Private Equity

Areas of investment

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Manufacturing
  • Medical
Summary

Auriga Partners is the famous VC, which was founded in 1998. The venture was found in Europe in France. The main department of described VC is located in the Paris.

Among the most successful fund investment fields, there are Medical Device, Medical. Besides, a startup requires to be at the age of 11-15 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Nexthink, Ekinops, Hybrigenics. For fund there is a match between the location of its establishment and the land of its numerous investments - France. The fund has no specific favorite in a number of founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low.

The standard case for the fund is to invest in rounds with 3-4 partakers. Despite the Auriga Partners, startups are often financed by Omnes Capital, Bpifrance, XAnge. The meaningful sponsors for the fund in investment in the same round are Sofinnova Partners, Bpifrance, 123Venture. In the next rounds fund is usually obtained by Omnes Capital, 123Venture, Wellington Partners.

The fund is constantly included in 7-12 investment rounds annually. The top amount of exits for fund were in 2017. This Auriga Partners works on 9 percentage points less the average amount of lead investments comparing to the other organizations. The real fund results show that this VC is 12 percentage points less often commits exit comparing to other companies. The important activity for fund was in 2007. The common things for fund are deals in the range of 10 - 50 millions dollars.

This organization was formed by Bernard Daugeras, Jacques Chatain, Patrick Bamas. The overall number of key employees were 8.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Auriga Partners:
Typical Co-investors
Auriga Partners is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Auriga Partners:

Funds with similar focus

Funds from France
Funds with similar focus located in France:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Vade Secure

Email
Enterprise Software
Information Technology
Security
$33M31 May 2022 France, Hauts-de-France, France

Nexthink

Analytics
Information Technology
Software
$86M12 Dec 2018 Switzerland, " Switzerland"}

Exeliom

Biopharma
Biotechnology
Health Care
Pharmaceutical
$8M06 Jul 2018 Dijon, Bourgogne-Franche-Comté, France

Biotechnology
Health Care
Medical
$3M16 May 2018 France, Occitania

EnobraQ

Biotechnology
Chemical
$3M10 Apr 2018 France, Auvergne-Rhône-Alpes, France

Pherecydes Pharma

Biotechnology
Health Care
Medical Device
$10M16 Jan 2018 France, Ile-de-France, France

aveni

Electronics
Manufacturing
Semiconductor
$10M24 Oct 2017 France, Ile-de-France, France

Vectalys

Biotechnology
Manufacturing
Wellness
$1M13 Jun 2017 France, Occitania

VitaDX

Biotechnology
$1M06 Jun 2017 France, Ile-de-France

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Auriga Partners?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: